UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 10-Q
x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 2014
OR
¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
For the transition period from to .
Commission file number: 001-14057
KINDRED HEALTHCARE, INC.
(Exact name of registrant as specified in its charter)
Delaware |
|
61-1323993 |
(State or other jurisdiction of incorporation or organization) |
|
(I.R.S. Employer Identification No.) |
680 South Fourth Street Louisville, KY |
|
40202-2412 |
(Address of principal executive offices) |
|
(Zip Code) |
(502) 596-7300
(Registrant’s telephone number, including area code)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer,” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer |
|
x |
|
Accelerated filer |
|
¨ |
Non-accelerated filer |
|
¨ |
|
Smaller reporting company |
|
¨ |
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No x
Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.
Class of Common Stock |
|
Outstanding at April 30, 2014 |
Common stock, $0.25 par value |
|
54,789,120 shares |
1 of 67
KINDRED HEALTHCARE, INC.
FORM 10-Q
INDEX
|
|
Page |
PART I. FINANCIAL INFORMATION |
|
|
Item 1. |
Financial Statements (Unaudited): |
|
|
Condensed Consolidated Statement of Operations – for the three months ended March 31, 2014 and 2013 |
3 |
|
4 |
|
|
Condensed Consolidated Balance Sheet – March 31, 2014 and December 31, 2013 |
5 |
|
Condensed Consolidated Statement of Cash Flows – for the three months ended March 31, 2014 and 2013 |
6 |
|
7 |
|
Item 2. |
Management’s Discussion and Analysis of Financial Condition and Results of Operations |
34 |
Item 3. |
62 |
|
Item 4. |
63 |
|
PART II. OTHER INFORMATION |
|
|
Item 1. |
64 |
|
Item 2. |
65 |
|
Item 6. |
66 |
2
KINDRED HEALTHCARE, INC.
CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS
(Unaudited)
(In thousands, except per share amounts)
|
Three months ended |
|
|||||
|
March 31, |
|
|||||
|
2014 |
|
|
2013 |
|
||
|
|
|
|
|
|
|
|
Revenues |
$ |
1,299,557 |
|
|
$ |
1,275,659 |
|
|
|
|
|
|
|
|
|
Salaries, wages and benefits |
|
780,294 |
|
|
|
790,091 |
|
Supplies |
|
83,294 |
|
|
|
85,682 |
|
Rent |
|
82,474 |
|
|
|
77,957 |
|
Other operating expenses |
|
253,480 |
|
|
|
235,100 |
|
Other income |
|
(237 |
) |
|
|
(1,009 |
) |
Impairment charges |
|
74 |
|
|
|
187 |
|
Depreciation and amortization |
|
40,210 |
|
|
|
42,249 |
|
Interest expense |
|
25,808 |
|
|
|
28,171 |
|
Investment income |
|
(184 |
) |
|
|
(87 |
) |
|
|
1,265,213 |
|
|
|
1,258,341 |
|
Income from continuing operations before income taxes |
|
34,344 |
|
|
|
17,318 |
|
Provision for income taxes |
|
13,102 |
|
|
|
6,481 |
|
Income from continuing operations |
|
21,242 |
|
|
|
10,837 |
|
Discontinued operations, net of income taxes: |
|
|
|
|
|
|
|
Loss from operations |
|
(5,757 |
) |
|
|
(5,339 |
) |
Loss on divestiture of operations |
|
(3,006 |
) |
|
|
(2,025 |
) |
Loss from discontinued operations |
|
(8,763 |
) |
|
|
(7,364 |
) |
Net income |
|
12,479 |
|
|
|
3,473 |
|
Earnings attributable to noncontrolling interests |
|
(4,459 |
) |
|
|
(416 |
) |
Income attributable to Kindred |
$ |
8,020 |
|
|
$ |
3,057 |
|
|
|
|
|
|
|
|
|
Amounts attributable to Kindred stockholders: |
|
|
|
|
|
|
|
Income from continuing operations |
$ |
16,783 |
|
|
$ |
10,421 |
|
Loss from discontinued operations |
|
(8,763 |
) |
|
|
(7,364 |
) |
Net income |
$ |
8,020 |
|
|
$ |
3,057 |
|
|
|
|
|
|
|
|
|
Earnings per common share: |
|
|
|
|
|
|
|
Basic: |
|
|
|
|
|
|
|
Income from continuing operations |
$ |
0.31 |
|
|
$ |
0.20 |
|
Discontinued operations: |
|
|
|
|
|
|
|
Loss from operations |
|
(0.10 |
) |
|
|
(0.10 |
) |
Loss on divestiture of operations |
|
(0.06 |
) |
|
|
(0.04 |
) |
Loss from discontinued operations |
|
(0.16 |
) |
|
|
(0.14 |
) |
Net income |
$ |
0.15 |
|
|
$ |
0.06 |
|
|
|
|
|
|
|
|
|
Diluted: |
|
|
|
|
|
|
|
Income from continuing operations |
$ |
0.31 |
|
|
$ |
0.20 |
|
Discontinued operations: |
|
|
|
|
|
|
|
Loss from operations |
|
(0.10 |
) |
|
|
(0.10 |
) |
Loss on divestiture of operations |
|
(0.06 |
) |
|
|
(0.04 |
) |
Loss from discontinued operations |
|
(0.16 |
) |
|
|
(0.14 |
) |
Net income |
$ |
0.15 |
|
|
$ |
0.06 |
|
|
|
|
|
|
|
|
|
Shares used in computing earnings per common share: |
|
|
|
|
|
|
|
Basic |
|
52,641 |
|
|
|
52,062 |
|
Diluted |
|
52,711 |
|
|
|
52,083 |
|
Cash dividends declared and paid per common share |
$ |
0.12 |
|
|
$ |
− |
|
|
|
|
|
|
|
|
|
See accompanying notes.
3
KINDRED HEALTHCARE, INC.
CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME
(Unaudited)
(In thousands)
|
Three months ended |
|
|||||
|
2014 |
|
|
2013 |
|
||
Net income |
$ |
12,479 |
|
|
$ |
3,473 |
|
Other comprehensive income (loss): |
|
|
|
|
|
|
|
Available-for-sale securities (Note 8): |
|
|
|
|
|
|
|
Change in unrealized investment gains |
|
137 |
|
|
|
1,613 |
|
Reclassification of (gains) losses realized in net income |
|
(8 |
) |
|
|
119 |
|
Net change |
|
129 |
|
|
|
1,732 |
|
Interest rate swaps (Note 1): |
|
|
|
|
|
|
|
Change in unrealized gains (losses) |
|
(1,080 |
) |
|
|
844 |
|
Reclassification of ineffectiveness realized in net income |
|
32 |
|
|
|
− |
|
Reclassification of gains realized in net income, net of payments |
|
(5 |
) |
|
|
(5 |
) |
Net change |
|
(1,053 |
) |
|
|
839 |
|
Income tax expense (benefit) related to items of other comprehensive income |
|
379 |
|
|
|
(937 |
) |
Other comprehensive income (loss) |
|
(545 |
) |
|
|
1,634 |
|
Comprehensive income |
|
11,934 |
|
|
|
5,107 |
|
Earnings attributable to noncontrolling interests |
|
(4,459 |
) |
|
|
(416 |
) |
Comprehensive income attributable to Kindred |
$ |
7,475 |
|
|
$ |
4,691 |
|
See accompanying notes.
4
KINDRED HEALTHCARE, INC.
CONDENSED CONSOLIDATED BALANCE SHEET
(Unaudited)
(In thousands, except per share amounts)
|
March 31, |
|
|
December 31, |
|
||
|
2014 |
|
|
2013 |
|
||
ASSETS |
|
|
|
|
|
|
|
Current assets: |
|
|
|
|
|
|
|
Cash and cash equivalents |
$ |
49,048 |
|
|
$ |
35,972 |
|
Cash – restricted |
|
3,689 |
|
|
|
3,713 |
|
Insurance subsidiary investments |
|
95,855 |
|
|
|
96,295 |
|
Accounts receivable less allowance for loss of $44,397 – March 31, 2014 and $41,025 – December 31, 2013 |
|
979,598 |
|
|
|
916,529 |
|
Inventories |
|
25,633 |
|
|
|
25,780 |
|
Deferred tax assets |
|
32,258 |
|
|
|
37,920 |
|
Income taxes |
|
9,090 |
|
|
|
36,846 |
|
Other |
|
46,554 |
|
|
|
43,673 |
|
|
|
1,241,725 |
|
|
|
1,196,728 |
|
|
|
|
|
|
|
|
|
Property and equipment |
|
1,937,826 |
|
|
|
1,906,366 |
|
Accumulated depreciation |
|
(1,007,623 |
) |
|
|
(979,791 |
) |
|
|
930,203 |
|
|
|
926,575 |
|
|
|
|
|
|
|
|
|
Goodwill |
|
992,214 |
|
|
|
992,102 |
|
Intangible assets less accumulated amortization of $57,756 – March 31, 2014 and $52,211 – December 31, 2013 |
|
417,182 |
|
|
|
423,303 |
|
Assets held for sale |
|
17,555 |
|
|
|
20,978 |
|
Insurance subsidiary investments |
|
157,567 |
|
|
|
149,094 |
|
Deferred tax assets |
|
18,659 |
|
|
|
17,043 |
|
Other |
|
221,201 |
|
|
|
220,046 |
|
Total assets |
$ |
3,996,306 |
|
|
$ |
3,945,869 |
|
LIABILITIES AND EQUITY |
|
|
|
|
|
|
|
Current liabilities: |
|
|
|
|
|
|
|
Accounts payable |
$ |
167,552 |
|
|
$ |
181,772 |
|
Salaries, wages and other compensation |
|
351,581 |
|
|
|
361,192 |
|
Due to third party payors |
|
31,734 |
|
|
|
33,747 |
|
Professional liability risks |
|
65,439 |
|
|
|
60,993 |
|
Other accrued liabilities |
|
129,478 |
|
|
|
146,495 |
|
Long-term debt due within one year |
|
8,218 |
|
|
|
8,222 |
|
|
|
754,002 |
|
|
|
792,421 |
|
|
|
|
|
|
|
|
|
Long-term debt |
|
1,660,596 |
|
|
|
1,579,391 |
|
Professional liability risks |
|
248,740 |
|
|
|
246,230 |
|
Deferred credits and other liabilities |
|
207,067 |
|
|
|
206,611 |
|
|
|
|
|
|
|
|
|
Commitments and contingencies (Note 9) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity: |
|
|
|
|
|
|
|
Stockholders' equity: |
|
|
|
|
|
|
|
Common stock, $0.25 par value; authorized 175,000 shares; issued 54,777 shares – March 31, 2014 and 54,165 shares – December 31, 2013 |
|
13,694 |
|
|
|
13,541 |
|
Capital in excess of par value |
|
1,144,204 |
|
|
|
1,146,193 |
|
Accumulated other comprehensive loss |
|
(797 |
) |
|
|
(252 |
) |
Retained deficit |
|
(71,285 |
) |
|
|
(76,825 |
) |
|
|
1,085,816 |
|
|
|
1,082,657 |
|
Noncontrolling interests |
|
40,085 |
|
|
|
38,559 |
|
Total equity |
|
1,125,901 |
|
|
|
1,121,216 |
|
Total liabilities and equity |
$ |
3,996,306 |
|
|
$ |
3,945,869 |
|
See accompanying notes.
5
KINDRED HEALTHCARE, INC.
CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS
(Unaudited)
(In thousands)
|
Three months ended |
|
|||||
|
March 31, |
|
|||||
|
2014 |
|
|
2013 |
|
||
Cash flows from operating activities: |
|
|
|
|
|
|
|
Net income |
$ |
12,479 |
|
|
$ |
3,473 |
|
Adjustments to reconcile net income to net cash provided by (used in) operating activities: |
|
|
|
|
|
|
|
Depreciation and amortization |
|
41,304 |
|
|
|
52,954 |
|
Amortization of stock-based compensation costs |
|
2,585 |
|
|
|
2,248 |
|
Amortization of deferred financing costs |
|
2,397 |
|
|
|
2,613 |
|
Provision for doubtful accounts |
|
8,760 |
|
|
|
11,266 |
|
Deferred income taxes |
|
3,975 |
|
|
|
(344 |
) |
Impairment charges |
|
518 |
|
|
|
436 |
|
Loss on divestiture of discontinued operations |
|
3,006 |
|
|
|
2,025 |
|
Other |
|
2,044 |
|
|
|
420 |
|
Change in operating assets and liabilities: |
|
|
|
|
|
|
|
Accounts receivable |
|
(71,829 |
) |
|
|
(67,411 |
) |
Inventories and other assets |
|
(6,218 |
) |
|
|
(8,147 |
) |
Accounts payable |
|
(13,526 |
) |
|
|
(15,790 |
) |
Income taxes |
|
29,413 |
|
|
|
12,675 |
|
Due to third party payors |
|
(2,013 |
) |
|
|
(1,028 |
) |
Other accrued liabilities |
|
(28,649 |
) |
|
|
29,443 |
|
Net cash provided by (used in) operating activities |
|
(15,754 |
) |
|
|
24,833 |
|
Cash flows from investing activities: |
|
|
|
|
|
|
|
Routine capital expenditures |
|
(21,677 |
) |
|
|
(22,370 |
) |
Development capital expenditures |
|
(751 |
) |
|
|
(2,388 |
) |
Acquisitions, net of cash acquired |
|
(22,715 |
) |
|
|
− |
|
Sale of assets |
|
5,034 |
|
|
|
5,060 |
|
Purchase of insurance subsidiary investments |
|
(10,114 |
) |
|
|
(10,836 |
) |
Sale of insurance subsidiary investments |
|
8,762 |
|
|
|
10,002 |
|
Net change in insurance subsidiary cash and cash equivalents |
|
(6,599 |
) |
|
|
(33,096 |
) |
Change in other investments |
|
640 |
|
|
|
319 |
|
Other |
|
(551 |
) |
|
|
(144 |
) |
Net cash used in investing activities |
|
(47,971 |
) |
|
|
(53,453 |
) |
Cash flows from financing activities: |
|
|
|
|
|
|
|
Proceeds from borrowings under revolving credit |
|
508,700 |
|
|
|
483,500 |
|
Repayment of borrowings under revolving credit |
|
(425,800 |
) |
|
|
(459,200 |
) |
Repayment of other long-term debt |
|
(2,059 |
) |
|
|
(2,666 |
) |
Payment of deferred financing costs |
|
(270 |
) |
|
|
(202 |
) |
Distribution made to noncontrolling interests |
|
(2,933 |
) |
|
|
(491 |
) |
Issuance of common stock |
|
3,804 |
|
|
|
4 |
|
Dividends paid |
|
(6,514 |
) |
|
|
− |
|
Other |
|
1,873 |
|
|
|
332 |
|
Net cash provided by financing activities |
|
76,801 |
|
|
|
21,277 |
|
Change in cash and cash equivalents |
|
13,076 |
|
|
|
(7,343 |
) |
Cash and cash equivalents at beginning of period |
|
35,972 |
|
|
|
50,007 |
|
Cash and cash equivalents at end of period |
$ |
49,048 |
|
|
$ |
42,664 |
|
Supplemental information: |
|
|
|
|
|
|
|
Interest payments |
$ |
11,601 |
|
|
$ |
13,092 |
|
Income tax refunds |
|
25,894 |
|
|
|
9,631 |
|
See accompanying notes.
6
KINDRED HEALTHCARE, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
NOTE 1 – BASIS OF PRESENTATION
Business
Kindred Healthcare, Inc. is a healthcare services company that through its subsidiaries operates transitional care (“TC”) hospitals, inpatient rehabilitation hospitals (“IRFs”), nursing centers, assisted living facilities, a contract rehabilitation services business and a home health and hospice business across the United States (collectively, the “Company” or “Kindred”). At March 31, 2014, the Company’s hospital division operated 100 TC hospitals (certified as long-term acute care (“LTAC”) hospitals under the Medicare program) and five IRFs in 22 states. The Company’s nursing center division operated 99 nursing centers and six assisted living facilities in 22 states. The Company’s rehabilitation division provided rehabilitation services primarily in hospitals and long-term care settings. The Company’s care management division (formerly known as the Company’s home health and hospice division) primarily provided home health, hospice and private duty services from 157 locations in 13 states.
The Company has completed several transactions related to the divestiture or planned divestiture of unprofitable hospitals and nursing centers to improve its future operating results. For accounting purposes, the operating results of these businesses and the losses associated with these transactions have been classified as discontinued operations in the accompanying unaudited condensed consolidated statement of operations for all periods presented. Assets held for sale at March 31, 2014 have been measured at the lower of carrying value or estimated fair value less costs of disposal and have been classified as held for sale in the accompanying unaudited condensed consolidated balance sheet. See Note 2 for a summary of discontinued operations.
Recently issued accounting requirements
In April 2014, the Financial Accounting Standards Board (the “FASB”) issued authoritative guidance which changes the requirements for reporting discontinued operations. A disposal of a component of an entity or a group of components of an entity is required to be reported in discontinued operations if the disposal represents a strategic shift that has (or will have) a major effect on an entity’s operations and financial results when any of the following occurs: (1) the component or group of components meets the criteria to be classified as held for sale, (2) the component or group of components is disposed of by sale, or (3) the component or group of components is disposed of other than by sale (for example, abandonment). The entity shall present separately, for each comparative period, the assets and liabilities of the discontinued operation in the statement of financial position. In addition to the required disclosures for discontinued operations, entities will also be required to provide disclosures about a disposal of an individually significant component of an entity that does not qualify for discontinued operations presentation in the financial statements. The guidance also states an entity shall expand disclosures about significant continuing involvement with a discontinued operation, until the results of operations of the discontinued operation are no longer presented in the statement of operations. The guidance is applicable prospectively for all disposals that occur within annual periods beginning on or after December 15, 2014 and early adoption is permitted. The adoption of the guidance is not expected to have a material impact on the Company’s business, financial position, net income or liquidity but may have a material impact on the Company’s income from continuing operations if planned or completed disposals of components of the Company’s business do not qualify for discontinued operations under the new guidance.
7
KINDRED HEALTHCARE, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(Unaudited)
NOTE 1 – BASIS OF PRESENTATION (Continued)
Equity
The following table sets forth the changes in equity attributable to noncontrolling interests and equity attributable to Kindred stockholders for the three months ended March 31, 2014 and 2013 (in thousands):
For the three months ended March 31, 2014: |
Amounts |
|
|
|
|
|
Total |
|
|||
Balance at December 31, 2013 |
$ |
1,082,657 |
|
|
$ |
38,559 |
|
|
$ |
1,121,216 |
|
Comprehensive income: |
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
8,020 |
|
|
|
4,459 |
|
|
|
12,479 |
|
Other comprehensive loss |
|
(545 |
) |
|
|
– |
|
|
|
(545 |
) |
|
|
7,475 |
|
|
|
4,459 |
|
|
|
11,934 |
|
Issuance of common stock in connection with employee benefit plans |
|
3,804 |
|
|
|
– |
|
|
|
3,804 |
|
Shares tendered by employees for statutory tax withholdings upon issuance of common stock |
|
(5,319 |
) |
|
|
– |
|
|
|
(5,319 |
) |
Income tax benefit in connection with the issuance of common stock under employee benefit plans |
|
1,128 |
|
|
|
– |
|
|
|
1,128 |
|
Stock-based compensation amortization |
|
2,585 |
|
|
|
– |
|
|
|
2,585 |
|
Distribution made to noncontrolling interests |
|
– |
|
|
|
(2,933 |
) |
|
|
(2,933 |
) |
Dividends paid |
|
(6,514 |
) |
|
|
– |
|
|
|
(6,514 |
) |
Balance at March 31, 2014 |
$ |
1,085,816 |
|
|
$ |
40,085 |
|
|
$ |
1,125,901 |
|
For the three months ended March 31, 2013: |
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31, 2012 |
$ |
1,256,159 |
|
|
$ |
36,685 |
|
|
$ |
1,292,844 |
|
Comprehensive income: |
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
3,057 |
|
|
|
416 |
|
|
|
3,473 |
|
Other comprehensive income |
|
1,634 |
|
|
|
– |
|
|
|
1,634 |
|
|
|
4,691 |
|
|
|
416 |
|
|
|
5,107 |
|
Issuance of common stock in connection with employee benefit plans |
|
4 |
|
|
|
– |
|
|
|
4 |
|
Shares tendered by employees for statutory tax withholdings upon issuance of common stock |
|
(2,810 |
) |
|
|
– |
|
|
|
(2,810 |
) |
Income tax provision in connection with the issuance of common stock under employee benefit plans |
|
(1,569 |
) |
|
|
– |
|
|
|
(1,569 |
) |
Stock-based compensation amortization |
|
2,248 |
|
|
|
– |
|
|
|
2,248 |
|
Distribution made to noncontrolling interests |
|
– |
|
|
|
(491 |
) |
|
|
(491 |
) |
Balance at March 31, 2013 |
$ |
1,258,723 |
|
|
$ |
36,610 |
|
|
$ |
1,295,333 |
|
8
KINDRED HEALTHCARE, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(Unaudited)
NOTE 1 – BASIS OF PRESENTATION (Continued)
Derivative financial instruments
In December 2011, the Company entered into two interest rate swap agreements to hedge its floating interest rate on an aggregate of $225 million of debt outstanding under its senior secured term loan facility (the “Prior Term Loan Facility”) entered into in June 2011. The interest rate swaps had an effective date of January 9, 2012, and will expire on January 11, 2016. The Company is required to make payments based upon a fixed interest rate of 1.8925% calculated on the notional amount of $225 million. In exchange, the Company will receive interest on $225 million at a variable interest rate that is based upon the three-month London Interbank Offered Rate (“LIBOR”), subject to a minimum rate of 1.5%. The Company determined these interest rate swaps continue to qualify for cash flow hedge accounting treatment at March 31, 2014. However, an amendment to the Prior Term Loan Facility completed in May 2013 reduced the LIBOR floor from 1.5% to 1.0%, therefore some partial ineffectiveness will result through the expiration of the interest rate swap agreement.
In March 2014, the Company entered into an additional interest rate swap agreement to hedge its floating interest rate on an aggregate of $400 million of debt outstanding under the Term Loan Amendment Agreement (as defined). The interest rate swap had an effective date of April 9, 2014, and will expire on April 9, 2018. The Company is required to make payments based upon a fixed interest rate of 1.867% calculated on the notional amount of $400 million. In exchange, the Company will receive interest on $400 million at a variable interest rate that is based upon the three-month LIBOR, subject to a minimum rate of 1.0%. The Company determined this interest rate swap qualifies for cash flow hedge accounting treatment at March 31, 2014.
The Company records the effective portion of the gain or loss on these derivative financial instruments in accumulated other comprehensive income (loss) as a component of stockholders equity and records the ineffective portion of the gain or loss on these derivative financial instruments as interest expense. For the three months ended March 31, 2014, the ineffectiveness related to the interest rate swaps was immaterial.
The aggregate fair value of the interest rate swaps recorded in other accrued liabilities was $2.5 million and $1.4 million at March 31, 2014 and December 31, 2013, respectively. See Note 10.
Other information
The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the instructions for Form 10-Q of Regulation S-X and do not include all of the disclosures normally required by generally accepted accounting principles or those normally required in annual reports on Form 10-K. Accordingly, these financial statements should be read in conjunction with the audited consolidated financial statements of the Company for the year ended December 31, 2013 filed with the Securities and Exchange Commission (the “SEC”) on Form 10-K. The accompanying condensed consolidated balance sheet at December 31, 2013 was derived from audited consolidated financial statements, but does not include all disclosures required by generally accepted accounting principles.
The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the Company’s customary accounting practices. Management believes that financial information included herein reflects all adjustments necessary for a fair statement of interim results and, except as otherwise disclosed, all such adjustments are of a normal and recurring nature.
The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles and include amounts based upon the estimates and judgments of management. Actual amounts may differ from those estimates.
Reclassifications
Certain prior period amounts have been reclassified to conform with the current period presentation.
NOTE 2 – DISCONTINUED OPERATIONS
In accordance with the authoritative guidance for the impairment or disposal of long-lived assets, the divestitures or planned divestiture of unprofitable businesses discussed in Note 1 has been accounted for as discontinued operations. Accordingly, the results of operations of these businesses for all periods presented and the losses or impairments associated with these transactions have been classified as discontinued operations, net of income taxes, in the accompanying unaudited condensed consolidated statement of operations. At March 31, 2014, the Company held for sale one hospital and 59 nursing centers reported as discontinued operations.
9
KINDRED HEALTHCARE, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(Unaudited)
NOTE 2 – DISCONTINUED OPERATIONS (Continued)
On September 30, 2013, the Company entered into agreements with Ventas, Inc. (“Ventas”) to exit 60 nursing centers (collectively, the “2013 Expiring Facilities”). The current lease term for the 2013 Expiring Facilities was scheduled to expire in April 2015. Under the terms of the agreements, the lease term for the 2013 Expiring Facilities will now expire on September 30, 2014 unless the Company and Ventas are able to transfer the operations earlier. The Company transferred the operations of six of the 2013 Expiring Facilities to a new operator effective April 1, 2014 and transferred the operations of another 20 of the 2013 Expiring Facilities effective May 1, 2014. Another facility was closed and its operating license and equipment were sold during the three months ended March 31, 2014. Proceeds from the sale of equipment and inventory for the 2013 Expiring Facilities totaled $2.6 million for the three months ended March 31, 2014. For accounting purposes, the 2013 Expiring Facilities qualified as assets held for sale and the Company reflected the operating results as discontinued operations in the accompanying unaudited condensed consolidated statement of operations for all historical periods.
The Company allowed the lease to expire on a TC hospital during the three months ended March 31, 2014 resulting in a loss on divestiture primarily related to a write-off of an indefinite-lived intangible asset of $3.4 million ($2.1 million net of income taxes) for the three months ended March 31, 2014. The Company reflected the operating results of this TC hospital as discontinued operations in the accompanying unaudited condensed consolidated statement of operations for all historical periods.
A summary of discontinued operations follows (in thousands):
|
Three months ended |
|
|||||
|
2014 |
|
|
2013 |
|
||
Revenues |
$ |
126,702 |
|
|
$ |
333,075 |
|
Salaries, wages and benefits |
|
66,229 |
|
|
|
169,293 |
|
Supplies |
|
6,773 |
|
|
|
21,839 |
|
Rent |
|
15,192 |
|
|
|
31,691 |
|
Other operating expenses |
|
46,097 |
|
|
|
107,970 |
|
Other expense |
|
361 |
|
|
|
124 |
|
Impairment charges |
|
444 |
|
|
|
249 |
|
Depreciation |
|
1,094 |
|
|
|
10,705 |
|
Interest expense |
|
1 |
|
|
|
5 |
|
Investment income |
|
3 |
|
|
|
(12 |
) |
|
|
136,194 |
|
|
|
341,864 |
|
Loss from operations before income taxes |
|
(9,492 |
) |
|
|
(8,789 |
) |
Income tax benefit |
|
(3,735 |
) |
|
|
(3,450 |
) |
Loss from operations |
|
(5,757 |
) |
|
|
(5,339 |
) |
Loss on divestiture of operations |
|
(3,006 |
) |
|
|
(2,025 |
) |
Loss from discontinued operations |
$ |
(8,763 |
) |
|
$ |
(7,364 |
) |
The following table sets forth certain discontinued operating data by business segment (in thousands):
|
Three months ended |
|
|||||
|
2014 |
|
|
2013 |
|
||
Revenues: |
|
|
|
|
|
|
|
Hospital division |
$ |
4,426 |
|
|
$ |
76,952 |
|
Nursing center division |
|
122,276 |
|
|
|
256,123 |
|
|
$ |
126,702 |
|
|
$ |
333,075 |
|
Operating income (loss): |
|
|
|
|
|
|
|
Hospital division |
$ |
(619 |
) |
|
$ |
11,450 |
|
Nursing center division |
|
7,417 |
|
|
|
22,150 |
|
|
$ |
6,798 |
|
|
$ |
33,600 |
|
Rent: |
|
|
|
|
|
|
|
Hospital division |
$ |
591 |
|
|
$ |
2,558 |
|
Nursing center division |
|
14,601 |
|
|
|
29,133 |
|
|
$ |
15,192 |
|
|
$ |
31,691 |
|
Depreciation: |
|
|
|
|
|
|
|
Hospital division |
$ |
51 |
|
|
$ |
3,777 |
|
Nursing center division |
|
1,043 |
|
|
|
6,928 |
|
|
$ |
1,094 |
|
|
$ |
10,705 |
|
10
KINDRED HEALTHCARE, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(Unaudited)
NOTE 2 – DISCONTINUED OPERATIONS (Continued)
A summary of the net assets held for sale follows (in thousands):
|
March 31, |
|
|
December 31, |
|
||
Long-term assets: |
|
|
|
|
|
|
|
Property and equipment, net |
$ |
16,029 |
|
|
$ |
19,504 |
|
Other |
|
1,526 |
|
|
|
1,474 |
|
|
|
17,555 |
|
|
|
20,978 |
|
Current liabilities (included in other accrued liabilities) |
|
− |
|
|
|
(81 |
) |
|
$ |
17,555 |
|
|
$ |
20,897 |
|
NOTE 3 – ACQUISITIONS
During the three months ended March 31, 2014, the Company acquired the real estate of two previously leased nursing centers for $22.3 million. Annual rent associated with the nursing centers aggregated $2.0 million. The fair value of the assets acquired was measured using discounted cash flow methodologies which are considered Level 3 inputs (as described in Note 10).
The purchase price of the acquired leased nursing centers resulted from negotiations with the landlord that were based upon both the historical and expected future cash flows of the nursing centers and real estate values. The acquisitions were financed through operating cash flows and borrowings under the Company’s revolving credit facility.
NOTE 4 – REVENUES
Revenues are recorded based upon estimated amounts due from patients and third party payors for healthcare services provided, including anticipated settlements under reimbursement agreements with Medicare, Medicaid, Medicare Advantage and other third party payors. Revenues under third party agreements are subject to examination and retroactive adjustment. Provisions for estimated third party adjustments are provided in the period the related services are rendered. Differences between the amounts accrued and subsequent settlements are recorded in the periods the interim or final settlements are determined.
A summary of revenues by payor type follows (in thousands):
|
Three months ended |
|
|||||
|
2014 |
|
|
2013 |
|
||
Medicare |
$ |
554,349 |
|
|
$ |
555,080 |
|
Medicaid |
|
160,412 |
|
|
|
138,075 |
|
Medicare Advantage |
|
100,858 |
|
|
|
93,772 |
|
Other |
|
538,359 |
|
|
|
543,448 |
|
|
|
1,353,978 |
|
|
|
1,330,375 |
|
Eliminations |
|
(54,421 |
) |
|
|
(54,716 |
) |
|
$ |
1,299,557 |
|
|
$ |
1,275,659 |
|
11
KINDRED HEALTHCARE, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(Unaudited)
NOTE 5 – EARNINGS PER SHARE AND DIVIDENDS
Earnings per common share are based upon the weighted average number of common shares outstanding during the respective periods. The diluted calculation of earnings per common share includes the dilutive effect of stock options. The Company follows the provisions of the authoritative guidance for determining whether instruments granted in share-based payment transactions are participating securities, which requires that unvested restricted stock that entitles the holder to receive nonforfeitable dividends before vesting be included as a participating security in the basic and diluted earnings per common share calculation pursuant to the two-class method.
The Company paid a quarterly cash dividend of $0.12 per common share on March 27, 2014 to shareholders of record as of the close of business on March 6, 2014. Future declarations of quarterly dividends will be subject to the approval of Kindred’s Board of Directors.
A computation of earnings per common share follows (in thousands, except per share amounts):
|
Three months ended March 31, |
|
|||||||||||||
|
2014 |
|
|
2013 |
|
||||||||||
|
Basic |
|
|
Diluted |
|
|
Basic |
|
|
Diluted |
|
||||
Earnings: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amounts attributable to Kindred stockholders: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As reported in Statement of Operations |
$ |
16,783 |
|
|
$ |
16,783 |
|
|
$ |
10,421 |
|
|
$ |
10,421 |
|
Allocation to participating unvested restricted stockholders |
|
(521 |
) |
|
|
(521 |
) |
|
|
(294 |
) |
|
|
(294 |
) |
Available to common stockholders |
$ |
16,262 |
|
|
$ |
16,262 |
|
|
$ |
10,127 |
|
|
$ |
10,127 |
|
Discontinued operations, net of income taxes: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss from operations: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As reported in Statement of Operations |
$ |
(5,757 |
) |
|
$ |
(5,757 |
) |
|
$ |
(5,339 |
) |
|
$ |
(5,339 |
) |
Allocation to participating unvested restricted stockholders |
|
179 |
|
|
|
179 |
|
|
|
151 |
|
|
|
151 |
|
Available to common stockholders |
$ |
(5,578 |
) |
|
$ |
(5,578 |
) |
|
$ |
(5,188 |
) |
|
$ |
(5,188 |
) |
Loss on divestiture of operations: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As reported in Statement of Operations |
$ |
(3,006 |
) |
|
$ |
(3,006 |
) |
|
$ |
(2,025 |
) |
|
$ |
(2,025 |
) |
Allocation to participating unvested restricted stockholders |
|
93 |
|
|
|
93 |
|
|
|
57 |
|
|
|
57 |
|
Available to common stockholders |
$ |
(2,913 |
) |
|
$ |
(2,913 |
) |
|
$ |
(1,968 |
) |
|
$ |
(1,968 |
) |
Loss from discontinued operations: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As reported in Statement of Operations |
$ |
(8,763 |
) |
|
$ |
(8,763 |
) |
|
$ |
(7,364 |
) |
|
$ |
(7,364 |
) |
Allocation to participating unvested restricted stockholders |
|
272 |
|
|
|
272 |
|
|
|
208 |
|
|
|
208 |
|
Available to common stockholders |
$ |
(8,491 |
) |
|
$ |
(8,491 |
) |
|
$ |
(7,156 |
) |
|
$ |
(7,156 |
) |
Net income: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As reported in Statement of Operations |
$ |
8,020 |
|
|
$ |
8,020 |
|
|
$ |
3,057 |
|
|
$ |
3,057 |
|
Allocation to participating unvested restricted stockholders |
|
(249 |
) |
|
|
(249 |
) |
|
|
(86 |
) |
|
|
(86 |
) |
Available to common stockholders |
$ |
7,771 |
|
|
$ |
7,771 |
|
|
$ |
2,971 |
|
|
$ |
2,971 |
|
Shares used in the computation: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average shares outstanding - basic computation |
|
52,641 |
|
|
|
52,641 |
|
|
|
52,062 |
|
|
|
52,062 |
|
Dilutive effect of employee stock options |
|
|
|
|
|
70 |
|
|
|
|
|
|
|
21 |
|
Adjusted weighted average shares outstanding - diluted computation |
|
|
|
|
|
52,711 |
|
|
|
|
|
|
|
52,083 |
|
Earnings per common share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations |
$ |
0.31 |
|
|
$ |
0.31 |
|
|
$ |
0.20 |
|
|
$ |
0.20 |
|
Discontinued operations: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss from operations |
|
(0.10 |
) |
|
|
(0.10 |
) |
|
|
(0.10 |
) |
|
|
(0.10 |
) |
Loss on divestiture of operations |
|
(0.06 |
) |
|
|
(0.06 |
) |
|
|
(0.04 |
) |
|
|
(0.04 |
) |
Loss from discontinued operations |
|
(0.16 |
) |
|
|
(0.16 |
) |
|
|
(0.14 |
) |
|
|
(0.14 |
) |
Net income |
$ |
0.15 |
|
|
$ |
0.15 |
|
|
$ |
0.06 |
|
|
$ |
0.06 |
|
Number of antidilutive stock options excluded from shares used in the diluted earnings per common share calculation |
|
|
|
|
|
318 |
|
|
|
|
|
|
|
1,274 |
|
12
KINDRED HEALTHCARE, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(Unaudited)
NOTE 6 – BUSINESS SEGMENT DATA
The Company is organized into four operating divisions: the hospital division, the nursing center division, the rehabilitation division and the care management division. Based upon the authoritative guidance for business segments, the operating divisions represent five reportable operating segments, including (1) hospitals, (2) nursing centers, (3) skilled nursing rehabilitation services, (4) hospital rehabilitation services and (5) home health and hospice services (included in the care management division). These reportable operating segments are consistent with information used by the Company’s President and Chief Operating Officer to assess performance and allocate resources. The accounting policies of the operating segments are the same as those described in the summary of significant accounting policies. Prior period segment information has been reclassified to conform with the current period presentation.
For segment purposes, the Company defines segment operating income as earnings before interest, income taxes, depreciation, amortization and rent. Segment operating income reported for each of the Company’s operating segments excludes impairment charges, transaction costs and the allocation of corporate overhead.
Segment operating income for the three months ended March 31, 2013 included one-time bonus costs paid to employees who do not participate in the Company’s incentive compensation program of $20.1 million (hospital division – $8.0 million, nursing center division – $4.7 million, rehabilitation division – $6.3 million (skilled nursing rehabilitation services – $5.0 million and hospital rehabilitation services – $1.3 million), care management division – $0.8 million and corporate – $0.3 million).
13
KINDRED HEALTHCARE, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(Unaudited)
NOTE 6 – BUSINESS SEGMENT DATA (Continued)
The following table sets forth certain data by business segment (in thousands):
|
Three months ended |
|
|||||
|
2014 |
|
|
2013 |
|
||
Revenues: |
|
|
|
|
|
|
|
Hospital division |
$ |
657,453 |
|
|
$ |
671,206 |
|
Nursing center division |
|
281,572 |
|
|
|
275,141 |
|
Rehabilitation division: |
|
|
|
|
|
|
|
Skilled nursing rehabilitation services |
|
253,285 |
|
|
|
257,884 |
|
Hospital rehabilitation services |
|
73,964 |
|
|
|
74,523 |
|
|
|
327,249 |
|
|
|
332,407 |
|
Care management division |
|
87,704 |
|
|
|
51,621 |
|
|
|
1,353,978 |
|
|
|
1,330,375 |
|
Eliminations: |
|
|
|
|
|
|
|
Skilled nursing rehabilitation services |
|
(30,070 |
) |
|
|
(29,303 |
) |
Hospital rehabilitation services |
|
(23,689 |
) |
|
|
(24,200 |
) |
Nursing centers |
|
(662 |
) |
|
|
(1,213 |
) |
|
|
(54,421 |
) |
|
|
(54,716 |
) |
|
$ |
1,299,557 |
|
|
$ |
1,275,659 |
|
Income from continuing operations: |
|
|
|
|
|
|
|
Operating income (loss): |
|
|
|
|
|
|
|
Hospital division |
$ |
146,895 |
|
|
$ |
149,698 |
|
Nursing center division |
|
39,095 |
|
|
|
29,844 |
|
Rehabilitation division: |
|
|
|
|
|
|
|
Skilled nursing rehabilitation services |
|
17,358 |
|
|
|
12,373 |
|
Hospital rehabilitation services |
|
19,820 |
|
|
|
18,132 |
|
|
|
37,178 |
|
|
|
30,505 |
|
Care management division |
|
4,697 |
|
|
|
2,786 |
|
Corporate: |
|
|
|
|
|
|
|
Overhead |
|
(44,050 |
) |
|
|
(45,585 |
) |
Insurance subsidiary |
|
(406 |
) |
|
|
(509 |
) |
|
|
(44,456 |
) |
|
|
(46,094 |
) |
Impairment charges |
|
(74 |
) |
|
|
(187 |
) |
Transaction costs |
|
(683 |
) |
|
|
(944 |